CREB activation with enhanced expression of glycolytic enzymes was profoundly reduced in melanomas originating from co‐injection of melanoma cells with replicative senescent (Rep SEN) fibroblasts silenced for GCP‐2 (Figure 6). The gene discussed is CXCL6; the disease is melanoma.